Rituximab for the Treatment of Rheumatoid Arthritis-Associated Interstitial Pneumonia: A Pilot Study.

Trial Profile

Rituximab for the Treatment of Rheumatoid Arthritis-Associated Interstitial Pneumonia: A Pilot Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Nov 2014

At a glance

  • Drugs Rituximab (Primary)
  • Indications Interstitial lung diseases; Rheumatoid arthritis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 06 Feb 2012 Actual patient number 10 added as reported by ClinicalTrials.gov.
    • 06 Feb 2012 Actual end date Jun 2011 added as reported by ClinicalTrials.gov.
    • 06 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top